Viewing nowEldirotablet 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.

MFDS item code 201308368 · Approved 2013.07.24 · Insurance code 652603240
Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. It particularly reduces the risk of myocardial infarction, stroke, vascular surgeries, and angina in adults with risk factors for coronary heart disease and patients with type 2 diabetes. Additionally, it is used to lower total cholesterol, LDL cholesterol, and triglyceride levels in patients with hyperlipidemia and to increase HDL cholesterol. It is also effective in managing cholesterol levels in pediatric patients aged 10 to 17 with heterozygous familial hypercholesterolemia. Thus, this medication is widely utilized for improving cardiovascular diseases and hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only for those requiring an LDL cholesterol reduction of 45 % or greater). This medication is administered at doses ranging from 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into consideration the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medication is 10 ~ 80 mg once daily. Administer this medication in combination with other lipid-lowering therapies (e.g., LDL apheresis), or when such therapies are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients aged 70 years and older are generally similar to those in the adult patient population.
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg of this medication in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
This medication may cause muscle problems; therefore, if you experience severe muscle pain or weakness, or if your creatine kinase levels significantly increase, you must stop taking it immediately. People with severely impaired liver function or liver disease should not take this medication and should undergo regular liver function tests. Women who are pregnant, possibly pregnant, or breastfeeding should not take this medication. Children under the age of 10 should not take this medication, and children aged 10 to 17 should use it cautiously under a doctor's supervision. If an allergic reaction or skin rash, particularly a severe rash, occurs, you should stop taking the medication immediately and consult a doctor. This medication has many drug interactions, so caution is necessary when taken with specific antibiotics, antifungals, antivirals, some cholesterol-lowering agents, and grapefruit juice. Elderly patients or those with decreased kidney function are at higher risk for serious side effects like myopathy or rhabdomyolysis, so they should be particularly careful when taking it. If symptoms such as muscle pain, weakness, fever, or malaise occur while taking this medication, you must inform your doctor immediately, and if needed, tests should be conducted to check for muscle damage. It is important to avoid alcohol intake while taking this medication and to regularly monitor liver and muscle health. There is no specific antidote in case of overdose, so treatment should be based on symptoms, and monitoring liver function and muscle damage via blood tests is necessary. This medication should be kept out of the reach of children and stored in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.